Navani et al., Lancet Respir Med (2015).
American Cancer Society. Global Cancer Facts & Figures 2nd Edition (2011).
Neal I. Lindeman et al. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors, Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology (2014).